Lisa Mary Cherian

Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic

Kundakarla Bhanuprasad, Abi Manesh, Emily Devasagayam et al. · International Journal of Infectious Diseases · 2021 · 63 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +16

Extent of maxillary sinus surgery and its effect on instrument access, irrigation penetration, and disease clearance

Revadi Govindaraju, Lisa Mary Cherian, Luis Macias‐Valle et al. · International Forum of Allergy & Rhinology · 2019 · 19 citations

Dentistry, Maxillofacial Surgery, Surgery +17

Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study

Abi Manesh, Emily Devasagayam, Kundakarla Bhanuprasad et al. · Clinical Microbiology and Infection · 2023 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Effect of commercial nasal steroid preparation on bacterial growth

Lisa Mary Cherian, Clare Cooksley, Katharina Richter et al. · International Forum of Allergy & Rhinology · 2019 · 15 citations

Pharmacy, Pharmaceutics, Pharmacology +16

The clinical outcomes of medical therapies in chronic rhinosinusitis is independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial

Lisa Mary Cherian, Ahmed Bassiouni, Clare Cooksley et al. · Rhinology Journal · 2020 · 12 citations · Full text

Life Sciences, Microbiology, Pharmacotherapy +15